Nūhou
ʻO ka hoʻōla mua ʻana o CAR-T i ka maʻi leukemia lymphoblastic ʻāʻī B-cell e hōʻike ana i ka pono i manaʻo ʻole ʻia
Hōʻike kahi noiʻi hou i ka pono kupaianaha o ka lāʻau lapaʻau CAR-T cell i ka mālama ʻana i ka B-cell Acute Lymphoblastic Leukemia (B-ALL). ʻO ka noiʻi, e pili ana i ka laulima ʻana me BIOOCUS a me ka Halemai ʻo Lu Daopei, e hōʻike ana i nā holomua koʻikoʻi, e hoʻokumu ana i ka lāʻau lapaʻau ma ke ʻano he koho lapaʻau koʻikoʻi.
Hoʻololi nā lāʻau lapaʻau CAR-T Cell hou i ka mālama ʻana i nā maʻi ʻino o B Cell
Ke noiʻi nei nā kānaka noiʻi mai ka Halemai ʻo Lu Daopei a me nā hoa hana o ka honua i nā ʻano lapaʻau CAR-T cell hou loa, e hāʻawi ana i ka manaʻolana no nā poʻe maʻi me nā maʻi ʻino o nā cell B. Hōʻike kēia haʻawina i nā holomua i ka hoʻolālā a me ka hoʻohana ʻana, e hōʻike ana i nā hopena hoʻohiki a me ka hiki ke loaʻa nā hana hou e hiki mai ana.
Hoʻonui ʻia ka pono Antitumor o nā pūnaewele CD19 CAR-T 4-1BB-Based i ka mālama ʻana iā B-ALL
Ua hōʻike nā haʻawina lapaʻau hou nei e hōʻike ana nā pūnaewele CD19 CAR-T i hoʻokumu ʻia ma 4-1BB i ka hopena antitumor maikaʻi loa i hoʻohālikelike ʻia me nā pūnaewele CAR-T i hoʻokumu ʻia ma CD28 i ka mālama ʻana i ka relapsed a i ʻole refractory B cell acute lymphoblastic leukemia (r/r B-ALL).
Hōʻike ka lāʻau lapaʻau CD19 CAR-T haʻahaʻa o ka haukapila ʻo Lu Daopei i nā hopena maikaʻi i nā poʻe maʻi B-ALL
Ua hōʻike ʻia kahi noiʻi hou ma ka Halemai ʻo Lu Daopei i ka pono kiʻekiʻe a me ka palekana o ka lāʻau lapaʻau haʻahaʻa CD19 CAR-T cell i ka mālama ʻana i nā maʻi leukemia lymphoblastic B acute (B-ALL) paʻakikī a i ʻole ka relapsed. Ua hōʻike ka noiʻi, nona nā maʻi he 51, i kahi helu hoʻomaha piha kupaianaha me nā hopena ʻaoʻao liʻiliʻi.
Hoʻonui ka hoʻolālā hoʻolaha hou i ka palekana a me ka pono o ka CAR-T Therapy i ka Acute B Cell Leukemia
Ua hoʻolaha ka Halemai ʻo Lu Daopei a me Hebei Senlang Biotechnology i nā ʻike hoʻohiki mai kā lākou noiʻi hou e pili ana i ka palekana a me ka pono o ka lāʻau lapaʻau CAR-T no ka maʻi leukemia B cell acute. Hōʻike kēia hana like i ka hiki o nā hoʻolālā cell CAR-T hou e hoʻomaikaʻi i nā hopena o ka mea maʻi.
Ua hōʻike ka Haʻawina Hou i ka Palekana a me ka Pono o ka CAR-T Therapy i ka mālama ʻana i nā maʻi ʻino B-Cell
Ua hōʻike ʻia kahi noiʻi hou i alakaʻi ʻia e Kauka Zhi-tao Ying mai ka Halemai Kanesa o ke Kulanui ʻo Peking i ka palekana a me ka pono o ka lāʻau lapaʻau IM19 CAR-T cell i ka mālama ʻana i nā maʻi hematologic B-cell i hoʻihoʻi ʻia a me nā mea paʻakikī. Paʻi ʻia ma ka Ka Nūpepa Kina no nā Lāʻau Lapaʻau Hou, ua hōʻike ka noiʻi ua loaʻa i ka 11 o 12 mau maʻi ke kala piha ʻana me ka ʻole o nā hopena maikaʻi ʻole, e hōʻike ana i ka hiki o IM19 ma ke ʻano he koho lapaʻau hoʻohiki no nā maʻi me nā koho ʻē aʻe i kaupalena ʻia.
Nā Holomua Hou i nā Pūnaewele Killer Kūlohelohe (NK) ma luna o 50 mau makahiki
I nā makahiki he ʻelima i hala iho nei, ua hoʻololi ka noiʻi ʻana i nā pūnaewele Natural Killer (NK) i ko mākou ʻike i ka pale kūlohelohe, e hāʻawi ana i nā ala hou no ka maʻi kanesa a me nā lāʻau lapaʻau viral.
Ua mālama ʻia ke aʻo makahiki no ka hoʻokele koko lapaʻau a me ka ʻenehana hoʻoili koko ma ka haukapila ʻo Yanda Ludaopei
Ua mālama pono ʻia ka Hoʻomaʻamaʻa Makahiki 2024 no ka Hoʻokele Koko Lapaʻau a me ka ʻenehana Hoʻoili Koko ma ke kūlanakauhale ʻo Sanhe ma ka Halemai ʻo Yanda Ludaopei. ʻO ka pahuhopu o kēia hanana e hoʻoikaika i ka hoʻokele koko lapaʻau a me ka palekana o ka hoʻoili koko ma o nā hālāwai hoʻomaʻamaʻa piha i hele ʻia e nā loea mālama ola kino he 100 a ʻoi mai nā ʻoihana lapaʻau like ʻole.
Ka holomua i ka maʻi Autoimmune Pediatric: Hoʻōla ka CAR-T Cell Therapy i ka mea maʻi Lupus
Ua mālama pono ʻia kahi kaikamahine 16 makahiki me ka systemic lupus erythematosus (SLE) koʻikoʻi ma kahi noiʻi paionia ma ka Halemai o ke Kulanui ʻo Erlangen me ka hoʻohana ʻana i ka lāʻau lapaʻau CAR-T cell. ʻO kēia ka hoʻohana mua ʻana o kēia lāʻau lapaʻau no ka lupus pediatric, e hāʻawi ana i ka manaʻolana hou no nā keiki me nā maʻi autoimmune.
Ka Hoʻoikaika ʻana i ka Pono o PROTAC: He Haʻawina Hoʻomaka Hou
Ua hōʻike ʻia kahi noiʻi hou ma Nature Communications i nā ʻike koʻikoʻi i loko o nā ala hōʻailona kūloko e hoʻololi i ka pono o ka hoʻohaʻahaʻa protein i kuhikuhi ʻia me ka hoʻohana ʻana i nā PROTAC. Hiki i kēia ʻike ke hoʻomākaukau i ke ala no nā lāʻau lapaʻau ʻoi aku ka maikaʻi no ka maʻi kanesa a me nā maʻi ʻē aʻe.
Ke Paipai nei i ke Ola Kino a me ka Hoʻōla: Mālama i kēlā me kēia lā no nā maʻi Leukemia
ʻO ka hōʻoia ʻana i kahi ʻike lapaʻau palekana a ʻoluʻolu hoʻi no nā maʻi leukemia e pili ana i ka mālama pono ʻana i kēlā me kēia lā, me ka hoʻomaʻemaʻe ʻana i ke kaiapuni, ka hoʻomaʻemaʻe pilikino, ka meaʻai, a me ka hoʻoikaika kino kūpono. Hāʻawi kēia alakaʻi i nā ʻōlelo aʻoaʻo koʻikoʻi no ka mālama pono ʻana i kēlā me kēia lā e kākoʻo i ka hoʻōla ʻana.
Hōʻike ka NS7CAR-T Cell Therapy i ka ʻōlelo hoʻohiki no ka mālama ʻana iā R/R T-ALL/LBL
Ua hōʻike ʻia kahi noiʻi hou i ka pono a me ka palekana o ka lāʻau lapaʻau NS7CAR-T cell i ka mālama ʻana i ka relapsed a refractory T-cell acute lymphoblastic leukemia (R/R T-ALL) a me T-cell lymphoblastic lymphoma (R/R T-LBL). Hāʻawi kēia lāʻau lapaʻau i ka manaʻolana hou no nā poʻe maʻi me kēia mau ʻano maʻi ʻaʻai ikaika.